キッセイ薬品工業の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年3月
|
75,579
|
4,017
|
6,142
|
11,289
|
38,238
|
37,341
|
221,136
|
39,793
|
260,929
|
22,894
|
|
104,551
|
17,663
|
127,310
|
5.31%
|
8.13%
|
14.94%
|
84.75%
|
-1,677
|
8,690
|
-10,006
|
-2.22%
|
7,013
|
5.43%
|
4.68%
|
0.00024661
|
0.00024661
|
1779人
|
2023年3月
|
67,493
|
-1,129
|
598
|
10,634
|
35,118
|
32,375
|
194,814
|
26,386
|
221,200
|
25,893
|
|
100,641
|
14,957
|
125,576
|
-1.67%
|
0.89%
|
15.76%
|
88.07%
|
-6,679
|
6,001
|
-3,420
|
-9.9%
|
-678
|
5.36%
|
4.63%
|
0.00022831
|
0.00022831
|
1795人
|
2022年3月
|
65,381
|
-1,402
|
562
|
13,032
|
34,143
|
31,238
|
202,180
|
35,907
|
238,087
|
30,013
|
|
99,342
|
18,744
|
118,183
|
-2.14%
|
0.86%
|
19.93%
|
84.92%
|
1,533
|
10,776
|
-2,756
|
2.34%
|
12,309
|
6.17%
|
5.14%
|
0.0002802
|
0.0002802
|
1828人
|
2021年3月
|
69,044
|
1,505
|
3,476
|
5,378
|
36,322
|
32,722
|
219,953
|
48,908
|
268,861
|
20,456
|
|
92,965
|
18,245
|
109,270
|
2.18%
|
5.03%
|
7.79%
|
81.81%
|
-2,542
|
-9,329
|
-4,000
|
-3.68%
|
-11,871
|
2.6%
|
2.15%
|
0.00011325
|
0.00011325
|
1863人
|
2020年3月
|
63,234
|
1,857
|
2,429
|
2,888
|
28,340
|
34,894
|
192,970
|
38,824
|
231,794
|
36,329
|
|
96,677
|
17,024
|
106,461
|
2.94%
|
3.84%
|
4.57%
|
83.25%
|
13,934
|
490
|
-4,419
|
22.04%
|
14,424
|
1.54%
|
1.3%
|
0.00006031
|
0.00006031
|
1892人
|
2019年3月
|
72,297
|
6,202
|
7,169
|
5,535
|
26,735
|
45,562
|
182,707
|
30,815
|
213,522
|
26,325
|
|
95,782
|
13,801
|
106,026
|
8.58%
|
9.92%
|
7.66%
|
85.57%
|
6,346
|
-2,087
|
-2,306
|
8.78%
|
4,259
|
3.09%
|
2.59%
|
0.00011733
|
0.00011733
|
1907人
|
2018年3月
|
74,009
|
9,887
|
11,414
|
9,098
|
25,878
|
48,131
|
176,092
|
36,995
|
213,087
|
24,371
|
|
98,163
|
17,448
|
102,834
|
13.36%
|
15.42%
|
12.29%
|
82.64%
|
8,845
|
-2,959
|
-6,621
|
11.95%
|
5,886
|
5.45%
|
4.55%
|
0.00018826
|
0.00018826
|
1903人
|
2017年3月
|
71,706
|
8,491
|
9,638
|
7,765
|
25,076
|
46,630
|
157,783
|
29,018
|
186,801
|
27,109
|
|
97,218
|
15,656
|
101,755
|
11.84%
|
13.44%
|
10.83%
|
84.47%
|
6,441
|
-4,671
|
-3,766
|
8.98%
|
1,770
|
4.92%
|
4.09%
|
0.00015874
|
0.00015874
|
1905人
|
2016年3月
|
71,294
|
10,274
|
11,353
|
8,195
|
23,582
|
47,712
|
158,125
|
35,220
|
193,345
|
25,666
|
|
100,051
|
19,608
|
96,230
|
14.41%
|
15.92%
|
11.49%
|
81.78%
|
5,763
|
-5,685
|
-2,146
|
8.08%
|
78
|
5.31%
|
4.37%
|
0.00016689
|
0.00016689
|
1908人
|
2015年3月
|
70,110
|
8,334
|
10,584
|
7,188
|
24,063
|
46,047
|
150,720
|
30,764
|
181,484
|
27,241
|
|
97,361
|
18,934
|
95,565
|
11.89%
|
15.1%
|
10.25%
|
83.05%
|
6,667
|
-3,168
|
-10,081
|
9.51%
|
3,499
|
4.9%
|
4.06%
|
0.00014214
|
0.00014214
|
1883人
|
2014年3月
|
70,399
|
12,301
|
13,541
|
9,093
|
23,182
|
47,217
|
142,821
|
29,828
|
172,649
|
31,266
|
|
100,894
|
17,879
|
90,918
|
17.47%
|
19.23%
|
12.92%
|
82.72%
|
11,945
|
-2,315
|
-2,304
|
16.97%
|
9,630
|
6.55%
|
5.47%
|
0.00017667
|
0.00017667
|
1883人
|
2013年3月
|
62,491
|
7,761
|
8,849
|
5,019
|
21,146
|
41,345
|
134,784
|
25,244
|
160,028
|
23,937
|
|
92,262
|
15,577
|
83,832
|
12.42%
|
14.16%
|
8.03%
|
84.23%
|
9,287
|
-2,075
|
-2,038
|
14.86%
|
7,212
|
3.89%
|
3.3%
|
0.00009752
|
0.00009752
|
1894人
|
2012年3月
|
64,618
|
|
8,326
|
4,769
|
|
|
123,385
|
21,000
|
144,385
|
45,773
|
|
|
|
|
0.0%
|
12.88%
|
7.38%
|
85.46%
|
5,046
|
-2,776
|
-6,649
|
7.81%
|
2,270
|
|
|
0.00009135
|
0.00009135
|
1893人
|
2011年3月
|
64,393
|
|
6,936
|
4,004
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
10.77%
|
6.22%
|
|
|
|
|
|
|
|
|
0.00007378
|
0.00007378
|
1911人
|
2010年3月
|
62,178
|
|
7,221
|
4,371
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
11.61%
|
7.03%
|
|
|
|
|
|
|
|
|
0.00008052
|
0.00008052
|
1920人
|